C
C01BD05 Ibutilide
[C01BD] Antiarrhythmics, class III
[C01B] ANTIARRHYTHMICS, CLASS I AND III
[C01] CARDIAC THERAPY
[C] Cardiovascular system
Organism | Test type | Route | Dose (normalized dose) | Effect | Source |
---|---|---|---|---|---|
rat | LD | oral | > 500mg/kg (500mg/kg) | Teratology, The International Journal of Abnormal Development. Vol. 49, Pg. 406, 1994. | |
rat | LD50 | intravenous | 94200ug/kg (94.2mg/kg) | Teratology, The International Journal of Abnormal Development. Vol. 49, Pg. 406, 1994. | |
122647-31-8 | 136591-58-7 | 647I318 |
AB01568246_01 | ALOBUEHUHMBRLE-UHFFFAOYSA-N | API0006228 |
BDBM50131432 | C-21412 | C07753 |
C20H36N2O3S | CC-29459 | CHEBI:5856 |
CHEMBL533 | D08060 | DB00308 |
DTXSID20861271 | FT-0631106 | GTPL7200 |
HMS3741K11 | Ibutilid | Ibutilida |
Ibutilida [INN-Spanish] | Ibutilide | Ibutilide (INN) |
Ibutilide [BAN:INN] | Ibutilide [INN:BAN] | Ibutilidum |
Ibutilidum [INN-Latin] | LS-90123 | MCULE-5393489002 |
Methanesulfonamide, N-[4-[4-(ethylheptylamino)-1-hydroxybutyl]phenyl]- | N-(4-(4-(ethyl(heptyl)amino)-1-hydroxybutyl)phenyl)methanesulfonamide | N-[4-[4-(ethylheptylamino)-1-hydroxybutyl]phenyl]methanesulfonamide |
N-{4-[4-(Ethyl-heptyl-amino)-1-hydroxy-butyl]-phenyl}-methanesulfonamide | Q3791612 | SCHEMBL3719856 |
ibutilide, (+-)-isomer | n-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide |
DrugBank Name | Ibutilide |
DrugBank | DB00308 |
CAS Number | 100632-81-3, 122647-31-8, 122647-32-9, 130350-52-6, 136591-58-7 |
PubChem Compound | 60753 |
KEGG Compound ID | C07753 |
KEGG Drug | D00648 |
PubChem.Substance | 46507904 |
ChEBI | 5856 |
PharmGKB | PA449958 |
ChemSpider | 54755 |
BindingDB | 50131432.0 |
TTD | DAP000279 |
Wikipedia | Ibutilide |
DPD | 12005 |